This webinar is part of a series of informative webinars created to complement the iREACH 2023 podcast series, REACHing for Vaccine Equity. In March, we focus on Kidney Disease and Vaccines and a presentation from REACH recipients from the National Kidney Foundation of Michigan.
This session will focus on topics such as: how to research, write and develop dynamic presentations; what constitutes an effective professional presentation—getting your message across; how to deal with speaker’s…
On the final episode of the first season of AIMing to Inform, hear from Immediate Past AIM Chair and Connecticut immunization program manager Kathy Kudish.
This webinar is part of a series of informative webinars created to complement the iREACH 2023 podcast series, REACHing for Vaccine Equity. February’s topic focuses on heart disease and vaccines and features a presentation from REACH recipients from YMCA Health Savannah.
Explore evaluation-related checklists, tools, publications, and presentations organized by general evaluation topics assembled by AIM in collaboration with Mathematica.
This resource provides faith-based organizations with tools to assist in stopping the spread of COVID-19.
Coming soon! REACHing for Vaccine Equity is a limited-series podcast. Each episode provides examples of vaccine equity initiatives and tips for community leaders.
This PowerPoint slide set was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide updated, comprehensive information on COVID-19 disease.
REACHing for Vaccine Equity is a limited series podcast produced by the iREACH team at the Association of Immunization Managers (AIM). This series of informative episodes discusses how individuals living with chronic health conditions, including heart disease, diabetes, clinical depression, and more, can continue to thrive with the preventative power of getting vaccinated and adopting healthy behaviors.
This Corporate Alliance meeting on October 28 will allow members to hear the latest on the immunization program landscape and ongoing COVID-19 AIM activities.